Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?

Delphine S. Tuot, Laura C. Plantinga, Chi Yuan Hsu, Neil R. Powe

Research output: Contribution to journalArticle

Abstract

Background: Awareness of chronic kidney disease (CKD) is low. Efforts are underway to increase recognition of CKD among patients, assuming that such an increase will lead to better outcomes through greater adherence to proven therapies. Few studies have tested this assumption. Methods: CKD awareness, defined by a 'yes' answer to 'Have you ever been told by a healthcare provider you have weak or failing kidneys?', was assessed among 2,404 adults with CKD stages 1-4, who participated in the 2003-2008 National Health and Nutrition Examination Surveys. Odds of blood pressure (BP) control, self-reported use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), and glycemic control, were determined among those aware vs. unaware of their CKD. Results: Optimal BP control, ACEI/ARB use and glycemic control were low in the US adult population with CKD, although there was a recent increase in attainment of guideline-concordant BP control. Odds of BP control and ACEI/ARB use were not different among individuals aware of their CKD compared to those unaware (adjusted odds ratio (AOR) 0.91; 95% CI 0.52-1.58 and AOR 0.75; 0.44-1.30, respectively). CKD awareness among diabetic participants was not associated with glycemic control (AOR 0.41; 95% CI 0.14-1.18). Conclusion: Awareness of CKD is not associated with more optimal BP control, ACEI/ARB use or glycemic control. Future efforts in this area should further explore the measurement of CKD awareness and behaviors associated with CKD awareness.

Original languageEnglish (US)
Pages (from-to)191-197
Number of pages7
JournalAmerican Journal of Nephrology
Volume35
Issue number2
DOIs
StatePublished - Feb 2012
Externally publishedYes

Fingerprint

Chronic Renal Insufficiency
Guidelines
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Blood Pressure
Odds Ratio
Nutrition Surveys
Health Personnel
Kidney

Keywords

  • Awareness
  • Chronic kidney disease
  • Guidelines
  • National Health And Nutrition Examination Survey (NHANES)

ASJC Scopus subject areas

  • Nephrology

Cite this

Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes? / Tuot, Delphine S.; Plantinga, Laura C.; Hsu, Chi Yuan; Powe, Neil R.

In: American Journal of Nephrology, Vol. 35, No. 2, 02.2012, p. 191-197.

Research output: Contribution to journalArticle

Tuot, Delphine S. ; Plantinga, Laura C. ; Hsu, Chi Yuan ; Powe, Neil R. / Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?. In: American Journal of Nephrology. 2012 ; Vol. 35, No. 2. pp. 191-197.
@article{c24b0774c69f4743a19e43a99ca31e18,
title = "Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?",
abstract = "Background: Awareness of chronic kidney disease (CKD) is low. Efforts are underway to increase recognition of CKD among patients, assuming that such an increase will lead to better outcomes through greater adherence to proven therapies. Few studies have tested this assumption. Methods: CKD awareness, defined by a 'yes' answer to 'Have you ever been told by a healthcare provider you have weak or failing kidneys?', was assessed among 2,404 adults with CKD stages 1-4, who participated in the 2003-2008 National Health and Nutrition Examination Surveys. Odds of blood pressure (BP) control, self-reported use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), and glycemic control, were determined among those aware vs. unaware of their CKD. Results: Optimal BP control, ACEI/ARB use and glycemic control were low in the US adult population with CKD, although there was a recent increase in attainment of guideline-concordant BP control. Odds of BP control and ACEI/ARB use were not different among individuals aware of their CKD compared to those unaware (adjusted odds ratio (AOR) 0.91; 95{\%} CI 0.52-1.58 and AOR 0.75; 0.44-1.30, respectively). CKD awareness among diabetic participants was not associated with glycemic control (AOR 0.41; 95{\%} CI 0.14-1.18). Conclusion: Awareness of CKD is not associated with more optimal BP control, ACEI/ARB use or glycemic control. Future efforts in this area should further explore the measurement of CKD awareness and behaviors associated with CKD awareness.",
keywords = "Awareness, Chronic kidney disease, Guidelines, National Health And Nutrition Examination Survey (NHANES)",
author = "Tuot, {Delphine S.} and Plantinga, {Laura C.} and Hsu, {Chi Yuan} and Powe, {Neil R.}",
year = "2012",
month = "2",
doi = "10.1159/000335935",
language = "English (US)",
volume = "35",
pages = "191--197",
journal = "American Journal of Nephrology",
issn = "0250-8095",
publisher = "S. Karger AG",
number = "2",

}

TY - JOUR

T1 - Is awareness of chronic kidney disease associated with evidence-based guideline-concordant outcomes?

AU - Tuot, Delphine S.

AU - Plantinga, Laura C.

AU - Hsu, Chi Yuan

AU - Powe, Neil R.

PY - 2012/2

Y1 - 2012/2

N2 - Background: Awareness of chronic kidney disease (CKD) is low. Efforts are underway to increase recognition of CKD among patients, assuming that such an increase will lead to better outcomes through greater adherence to proven therapies. Few studies have tested this assumption. Methods: CKD awareness, defined by a 'yes' answer to 'Have you ever been told by a healthcare provider you have weak or failing kidneys?', was assessed among 2,404 adults with CKD stages 1-4, who participated in the 2003-2008 National Health and Nutrition Examination Surveys. Odds of blood pressure (BP) control, self-reported use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), and glycemic control, were determined among those aware vs. unaware of their CKD. Results: Optimal BP control, ACEI/ARB use and glycemic control were low in the US adult population with CKD, although there was a recent increase in attainment of guideline-concordant BP control. Odds of BP control and ACEI/ARB use were not different among individuals aware of their CKD compared to those unaware (adjusted odds ratio (AOR) 0.91; 95% CI 0.52-1.58 and AOR 0.75; 0.44-1.30, respectively). CKD awareness among diabetic participants was not associated with glycemic control (AOR 0.41; 95% CI 0.14-1.18). Conclusion: Awareness of CKD is not associated with more optimal BP control, ACEI/ARB use or glycemic control. Future efforts in this area should further explore the measurement of CKD awareness and behaviors associated with CKD awareness.

AB - Background: Awareness of chronic kidney disease (CKD) is low. Efforts are underway to increase recognition of CKD among patients, assuming that such an increase will lead to better outcomes through greater adherence to proven therapies. Few studies have tested this assumption. Methods: CKD awareness, defined by a 'yes' answer to 'Have you ever been told by a healthcare provider you have weak or failing kidneys?', was assessed among 2,404 adults with CKD stages 1-4, who participated in the 2003-2008 National Health and Nutrition Examination Surveys. Odds of blood pressure (BP) control, self-reported use of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin receptor blockers (ARB), and glycemic control, were determined among those aware vs. unaware of their CKD. Results: Optimal BP control, ACEI/ARB use and glycemic control were low in the US adult population with CKD, although there was a recent increase in attainment of guideline-concordant BP control. Odds of BP control and ACEI/ARB use were not different among individuals aware of their CKD compared to those unaware (adjusted odds ratio (AOR) 0.91; 95% CI 0.52-1.58 and AOR 0.75; 0.44-1.30, respectively). CKD awareness among diabetic participants was not associated with glycemic control (AOR 0.41; 95% CI 0.14-1.18). Conclusion: Awareness of CKD is not associated with more optimal BP control, ACEI/ARB use or glycemic control. Future efforts in this area should further explore the measurement of CKD awareness and behaviors associated with CKD awareness.

KW - Awareness

KW - Chronic kidney disease

KW - Guidelines

KW - National Health And Nutrition Examination Survey (NHANES)

UR - http://www.scopus.com/inward/record.url?scp=84856200328&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856200328&partnerID=8YFLogxK

U2 - 10.1159/000335935

DO - 10.1159/000335935

M3 - Article

C2 - 22286715

AN - SCOPUS:84856200328

VL - 35

SP - 191

EP - 197

JO - American Journal of Nephrology

JF - American Journal of Nephrology

SN - 0250-8095

IS - 2

ER -